CLINICAL TRIALS PROFILE FOR COLESEVELAM HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for colesevelam hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00145574 ↗ | Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol | Completed | Daiichi Sankyo Inc. | Phase 4 | 2005-11-01 | This study will evaluate the lipid-lowering effect and safety of colesevelam therapy administered to heterozygous familial pediatric patients 10 through 17 years of age who are on a stable dose of a pediatric-approved statin monotherapy (atorvastatin, lovastatin, simvastatin or pravastatin), or who are treatment naive to lipid-lowering therapy. |
| NCT00145574 ↗ | Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol | Completed | Daiichi Sankyo, Inc. | Phase 4 | 2005-11-01 | This study will evaluate the lipid-lowering effect and safety of colesevelam therapy administered to heterozygous familial pediatric patients 10 through 17 years of age who are on a stable dose of a pediatric-approved statin monotherapy (atorvastatin, lovastatin, simvastatin or pravastatin), or who are treatment naive to lipid-lowering therapy. |
| NCT00147719 ↗ | WelChol® With Metformin in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs. |
| NCT00147719 ↗ | WelChol® With Metformin in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo, Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs. |
| NCT00147745 ↗ | Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 2 | 2005-06-01 | This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes |
| NCT00147745 ↗ | Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes | Completed | Daiichi Sankyo, Inc. | Phase 2 | 2005-06-01 | This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes |
| NCT00147758 ↗ | WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes | Completed | Daiichi Sankyo Inc. | Phase 3 | 2004-06-01 | The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for colesevelam hydrochloride
Condition Name
Clinical Trial Locations for colesevelam hydrochloride
Trials by Country
Clinical Trial Progress for colesevelam hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for colesevelam hydrochloride
Sponsor Name
